428
Views
4
CrossRef citations to date
0
Altmetric
Papers

Identification of illicit drugs in vapes by GC-MS

&
Pages 650-659 | Received 18 Feb 2016, Accepted 22 Apr 2016, Published online: 31 May 2016

References

  • Pisinger C, Døssing M. A systematic review of health effects of electronic cigarettes. Prev. Med. 2014;69: 248–260.
  • Schober W, Szendrei K, Matzen W, Osiander-Fuchs H, Heitmann D, Schettgen T, Jörres RA, Fromme H. Use of electronic cigarettes (e-cigarettes) impairs indoor air quality and increases FeNO levels of e-cigarette consumers. Int. J. Hyg. Environ. Health. 2014;217: 628–637.
  • Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L. Nicotine levels in electronic cigarettes. Nicotine Tob. Res. 2013;15: 158–166.
  • Etter JF, Zäther E, Svensson S. Analysis of refill liquids for electronic cigarettes. Addiction. 2013;108: 1671–1679.
  • Behar RZ, Davis B, Wang Y, Bahl V, Lin S, Talbot P. Identification of toxicants in cinnamon-flavored electronic cigarette refill fluids. Toxicol. In Vitro. 2014;28: 198–208.
  • United Nations Office of Drugs and Crime. Recommended methods for testing opium, morphine and heroin: manual for use by national drug testing laboratories. Vienna: United Nations; 1998.
  • United Nations Office of Drugs and Crime. Recommended methods for the identification and analysis of amphetamine, methamphetamine and their ring-substituted analogues in seized materials: manual for use by national drug testing laboratories. Vienna: United Nations; 2006.
  • United Nations Office of Drugs and Crime. Recommended methods for the identification and analysis of synthetic cannabinoid receptor agonists in seized materials: manual for use by national drug testing laboratories. Vienna: United Nations; 2013.
  • Chan KB, Pakiam C, Rahim, RA. Psychoactive plant abuse: the identification of mitragynine in ketum and in ketum preparations. B. Narcotics, 2005;LVII: 249–256.
  • Ullucci PA, Cadoret R, Stasiowski PD, Martin HF. A comprehensive GC/MS Drug Screening Procedure. J. Anal. Toxicol. 1978;2: 33–38.
  • Nair H, Woo F, Hoofnagle AN, Baird GS. Clinical validation of a highly sensitive GC-MS platform for routine urine drug screening and real-time reporting of up to 212 drugs. J. Toxicol. 2013; doi: 10.1155/2013/329407.
  • Peters FT. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology. Clin. Biochem. 2011;44: 54–65.
  • Wu AH, French D. Implementation of liquid chromatography/mass spectrometry into the clinical laboratory. Clin. Chim. Acta. 2013;420: 4–10.
  • Wu AH. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology. Clin. Toxicol. 2012;50: 733–742.
  • United Nations Office of Drugs and Crime. Guidance for validation of analytical methodology and calibration of equipment used for testing of illicit drugs in seized materials and biological specimens. Vienna: United Nations; 2009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.